$27.51
Price
$4.7B
Market Cap
17.7
P/E Ratio
33.8
Forward P/E
$1.55
EPS (TTM)
—
Dividend Yield
$847M
Cash
$52M
Total Debt
169M
Shares Out
$13.40
$28.35
52-Week Range
Institutional Ownership of ACADIA PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ACADIA PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for ACADIA PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $1.0M
0
Buys
3
Sells
-1.0M
Net
0
Grants
Largest
$671K
Daly
$243K
Schneyer
$97K
Kihara
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 18, 2025 | James Kihara | PRINCIPAL ACCOUNTING OFFICER | SELL | 4.1K | $23.69 | $97K |
| Nov 18, 2025 | Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | SELL | 10.3K | $23.69 | $243K |
| Nov 10, 2025 | James M Daly | Director | SELL | 30.0K | $22.37 | $671K |